Literature DB >> 24310756

Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.

Maria Laura Ester Bianchi1, Anna Losurdo, Chiara Di Blasi, Massimo Santoro, Marcella Masciullo, Giulia Conte, Venanzio Valenza, Antonello Damiani, Giacomo Della Marca, Gabriella Silvestri.   

Abstract

PURPOSE: Myotonic dystrophy types 1 (DM1) and 2 (DM2) are the most common muscular dystrophies in adulthood. A high prevalence of excessive daytime sleepiness (EDS) and sleep disordered breathing was documented in DM1; however, there are limited data available regarding DM2. Goals of the study were: (1) to evaluate the prevalence of sleep apnea in a large cohort of patients (71 DM1 and 14 DM2) and (2) to analyze correlations among such disorders and clinical features of myotonic dystrophies.
METHODS: All patients underwent clinical examination, subjective sleep evaluation, and home based cardiorespiratory monitoring, and most of them performed pulmonary function tests and oropharyngeal-oesophageal scintigraphy (OPES).
RESULTS: Almost 45% of patients reported poor sleep quality; only 20% of them referred EDS. Sleep studies documented sleep apnea, mostly obstructive, in 69% DM1 patients and 43% DM2 patients; overall, 28% of cases needed non-invasive ventilation. Neither age, gender, illness duration, body mass index, muscle involvement, OPES respiratory function indexes, nor n(CTG) in leukocytes were predictive of sleep apnea in DM1 patients. Conversely, in DM1 the central apnea-hypopnea index is correlated with the oral transit time estimated by OPES, whereas in DM2 apnea indexes are correlated with pulmonary function parameters.
CONCLUSIONS: Sleep apnea is highly prevalent in both forms of myotonic dystrophies. In DM1, no clinical parameters appear to be predictive, while age appears to influence the severity of the obstructive variant; in DM2, the severity of sleep apnea is correlated with the degree of respiratory muscle involvement. Considering the harmful consequences of sleep apnea on cardiorespiratory function, our findings suggest including PSG in the follow-up of myotonic dystrophies.

Entities:  

Mesh:

Year:  2013        PMID: 24310756     DOI: 10.1007/s11325-013-0921-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  44 in total

1.  Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.

Authors:  S Ono; K Takahashi; K Jinnai; F Kanda; Y Fukuoka; H Kurisaki; S Mitake; T Inagaki; T Yamano; K Nagao
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

2.  Italian version of the Epworth sleepiness scale: external validity.

Authors:  L Vignatelli; G Plazzi; A Barbato; L Ferini-Strambi; R Manni; F Pompei; R D'Alessandro
Journal:  Neurol Sci       Date:  2003-02       Impact factor: 3.307

3.  Alveolar hypoventilation and hyperosmnia in myotonic dystrophy.

Authors:  G Coccagna; M Mantovani; C Parchi; F Mironi; E Lugaresi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-10       Impact factor: 10.154

4.  Electrophysiological evaluation of oropharyngeal swallowing in myotonic dystrophy.

Authors:  C Ertekin; N Yüceyar; H Karasoy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

5.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

6.  A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1.

Authors:  L Laberge; P Bégin; Y Dauvilliers; M Beaudry; M Laforte; S Jean; J Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-11       Impact factor: 10.154

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split?

Authors:  Luc Laberge; Yves Dauvilliers; Paul Bégin; Louis Richer; Stéphane Jean; Jean Mathieu
Journal:  Neuromuscul Disord       Date:  2009-04-29       Impact factor: 4.296

9.  Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders.

Authors:  Clete A Kushida; Michael R Littner; Max Hirshkowitz; Timothy I Morgenthaler; Cathy A Alessi; Dennis Bailey; Brian Boehlecke; Terry M Brown; Jack Coleman; Leah Friedman; Sheldon Kapen; Vishesh K Kapur; Milton Kramer; Teofilo Lee-Chiong; Judith Owens; Jeffrey P Pancer; Todd J Swick; Merrill S Wise
Journal:  Sleep       Date:  2006-03       Impact factor: 5.849

10.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

View more
  10 in total

Review 1.  Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.

Authors:  Andrea Romigi; Michelangelo Maestri; Carmine Nicoletta; Giuseppe Vitrani; Marco Caccamo; Gabriele Siciliano; Enrica Bonanni; Diego Centonze; Alessandro Sanduzzi
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-09       Impact factor: 5.081

Review 2.  Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.

Authors:  Andrea Romigi; Valentina Franco; Fabio Placidi; Claudio Liguori; Emanuele Rastelli; Giuseppe Vitrani; Diego Centonze; Roberto Massa
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-31       Impact factor: 5.081

3.  Sleep-related breathing disorders in facioscapulohumeral dystrophy.

Authors:  Maya Runte; Jens Spiesshoefer; Anna Heidbreder; Michael Dreher; Peter Young; Tobias Brix; Matthias Boentert
Journal:  Sleep Breath       Date:  2019-04-26       Impact factor: 2.655

4.  Characterization of individuals with selected muscular dystrophies from the expanded pilot of the Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet) in the United States.

Authors:  Bailey Wallace; K Tiffany Smith; Shiny Thomas; Kristin M Conway; Christina Westfield; Jennifer G Andrews; Richard O Weinert; Thuy Quynh N Do; Natalie Street
Journal:  Birth Defects Res       Date:  2020-07-24       Impact factor: 2.661

5.  Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies.

Authors:  Marta Banach; Jakub Antczak; Rafał Rola
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-12       Impact factor: 2.570

6.  Anesthetic Considerations in a Patient with Myotonic Dystrophy for Hip Labral Repair.

Authors:  Ramon Go; David Wang; Danielle Ludwin
Journal:  Case Rep Anesthesiol       Date:  2017-02-20

7.  Management of respiratory complications and rehabilitation in individuals with muscular dystrophies: 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Milan, January 25-26, 2019).

Authors:  Fabrizio Rao; Giancarlo Garuti; Michele Vitacca; Paolo Banfi; Fabrizio Racca; Renato Cutrera; Martino Pavone; Marina Pedemonte; Matteo Schisano; Stefania Pedroni; Jacopo Casiraghi; Andrea Vianello; Valeria A Sansone
Journal:  Acta Myol       Date:  2021-03-31

8.  Assessment of Respiratory Function and Need for Noninvasive Ventilation in a Cohort of Patients with Myotonic Dystrophy Type 1 Followed at One Single Expert Center.

Authors:  Carola R Ferrari Aggradi; Elisa Falcier; Andrea Lizio; Alice Pirola; Jacopo Casiraghi; Alice Zanolini; Elena Carraro; Luca Mauro; Fabrizio Rao; Elisabetta Roma; Antonino Iannello; Elisa De Mattia; Andrea Barp; Sara Lupone; Valentina Gatti; Cristina Italiano; Valeria A Sansone
Journal:  Can Respir J       Date:  2022-06-18       Impact factor: 2.130

Review 9.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

10.  Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1.

Authors:  Valeria A Sansone; Paola Proserpio; Luca Mauro; Andrea Lizio Biostat; Erica Frezza; Andrea Lanza; Paola Rogliani; Gabriella Pezzuto; Elisa Falcier; Carola Ferrari Aggradi; Alice Pirola; Fabrizio Rao; Elisabetta Roma; Claudia Galluzzi; Matteo Spanetta; Federica Cattaneo; Annalisa Rubino; Elio Clemente Agostoni; Federica Amico; Alice Zanolini; Francesca Izzi; Giulia Greco; Andrea Romigi; Claudio Liguori; Lino Nobili; Fabio Placidi; Roberto Massa
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.